secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELLAS Life Sciences Group, Inc. (SLS)
CIK:        0001390478
Form:       8-K
Filed at:   2025-10-27T23:59:59+00:00
Accession:  0001104659-25-102345
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SELLAS receives $31M from warrant exercise; issues new warrants at $2 strike
----------------------------------------------------------------------------

- Existing warrants for up to 22,363,714 shares exercised immediately for $31M gross proceeds.
- New registered warrants issued for 22,363,714 shares at $2.00, exercisable immediately for five years.
- Financial advisors A.G.P. and Maxim Group receive 5.75% of gross proceeds fee plus up to $60K legal reimbursement.
- Company restricted for 75 days from issuing equity or filing registration statements; 12-month ban on variable-rate transactions.
- Virtual R&D Day on AML scheduled for October 29, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1390478/000110465925102345/0001104659-25-102345-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1390478/000110465925102345/tm2529505d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-102345

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer